Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

To evaluate the efficacy and safety of capecitabine and cisplatin in patients with recurrent gastric cancer after fluoropyrimidine-based adjuvant therapy. Patients with histologically confirmed and measurable advanced gastric cancer that had relapsed after fluoropyrimidine-based adjuvant chemotherap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2005
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361863/
https://ncbi.nlm.nih.gov/pubmed/15655540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602336
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia